Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar;47(3):981-997.
doi: 10.1007/s00261-021-03399-9. Epub 2022 Jan 3.

Imaging mimickers of cholangiocarcinoma: a pictorial review

Affiliations
Review

Imaging mimickers of cholangiocarcinoma: a pictorial review

Si Min Chiow et al. Abdom Radiol (NY). 2022 Mar.

Abstract

Cholangiocarcinoma (CCA) is the second most common primary hepatobiliary malignancy and presents as three separate morphological subtypes; namely mass-forming, periductal-infiltrating, and intraductal-growing patterns. Each of these subtypes have distinct imaging characteristics, as well as a variety of benign and malignant mimics, making accurate diagnosis of CCA on imaging challenging. Whilst histopathological examination is required to arrive at a definitive diagnosis, it is still important for radiologists to be cognizant of these entities and provide reasonable differential diagnoses, as these potentially have a large impact on patient management. This pictorial essay illustrates the three morphological subtypes of CCA, as well as some important mimics for each subtype, that are encountered in clinical practice.

Keywords: Cholangiocarcinoma mimickers; Intraductal-growing cholangiocarcinoma; Mass-forming cholangiocarcinoma; Periductalinfiltrating cholangiocarcinoma.

PubMed Disclaimer

Comment in

References

    1. Khan, S. A., S. Tavolari and G. Brandi (2019). Cholangiocarcinoma: Epidemiology and risk factors. Liver Int 39 Suppl 1: 19-31. - PubMed
    1. Yamasaki, S. (2003). Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg 10(4): 288-291. - PubMed
    1. Tajima, Y., T. Kuroki, K. Fukuda, N. Tsuneoka, J. Furui and T. Kanematsu (2004). An intraductal papillary component is associated with prolonged survival after hepatic resection for intrahepatic cholangiocarcinoma. Br J Surg 91(1): 99-104. - PubMed
    1. Morimoto, Y., Y. Tanaka, T. Ito, M. Nakahara, H. Nakaba, T. Nishida, M. Fujikawa, S. Yamamoto and T. Kitagawa (2003). Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 10(6): 432-440. - PubMed
    1. Banales, J. M., J. J. G. Marin, A. Lamarca, P. M. Rodrigues, S. A. Khan, L. R. Roberts, V. Cardinale, G. Carpino, J. B. Andersen, C. Braconi, D. F. Calvisi, M. J. Perugorria, L. Fabris, L. Boulter, R. I. R. Macias, E. Gaudio, D. Alvaro, S. A. Gradilone, M. Strazzabosco, M. Marzioni, C. Coulouarn, L. Fouassier, C. Raggi, P. Invernizzi, J. C. Mertens, A. Moncsek, S. Rizvi, J. Heimbach, B. G. Koerkamp, J. Bruix, A. Forner, J. Bridgewater, J. W. Valle and G. J. Gores (2020). Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol 17(9): 557-588. - PubMed - PMC

MeSH terms

LinkOut - more resources